Skip to search formSkip to main contentSkip to account menu

Gadoxetate Disodium

Known as: Disodium (N-((2S)-2-(bis(carboxymethyl)amino)-3-(p-ethoxyphenyl)propyl)-N-(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))gadolinate(2-), disodium gadoxetate, gadolinium (4S)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanoic acid disodium salt 
A paramagnetic contrast agent consisting of the disodium salt of the gadolinium ion chelated with the lipophilic moiety ethoxybenzyl (EOB) bound to… 
National Institutes of Health

Related topics

Related topics

3 relations
GADOXETATE DISODIUM 181.43 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [EOVIST]Gadoxetic acid

Broader (1)

gadolinium ethoxybenzyl DTPA

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: Multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging
ObjectivesTo assess the usefulness of multiple arterial phase (AP) of gadoxetic acid-enhanced MRI using view-sharing of two… 
2018
2018
Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
ObjectivesTo assess if the administration of gadoxetate disodium (Gd-EOB-DTPA) significantly affects hepatic magnetic resonance… 
2015
2015
Gadoxetate Disodium-Enhanced MRI to Differentiate Dysplastic Nodules and Grade of Hepatocellular Carcinoma: Correlation With Histopathology.
OBJECTIVE The objective of our study was to determine quantitative differences to differentiate low-grade from high-grade… 
2015
2015
Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma
PurposeTo investigate the utility of gadoxetate disodium-enhanced hepatic MRI (EOB-MRI) for stereotactic body radiotherapy (SBRT… 
2013
2013
MR imaging of renal collecting system with gadoxetate disodium: Feasibility for MR urography
To determine the feasibility of using gadoxetate disodium for MR urography. 
2012
2012
Gadolinium accumulation and fibrosis in the liver after administration of gadoxetate disodium in a rat model of active hepatic fibrosis.
PURPOSE To evaluate the effect of gadoxetate disodium on fibrosis in a rat model of active hepatic fibrosis. MATERIALS AND… 
2011
2011
Evaluation of the Effect of Two Gadolinium-Containing Contrast-Enhancing Agents, Gadobutrol and Gadoxetate Disodium, on Colorimetric Calcium Determinations in Serum and Plasma
Objective:To determine the extent to which the gadolinium-containing contrast agents, gadobutrol (Gadovist) and gadoxetate… 
2011
2011
Interstitial MR lymphography in mice with gadopentetate dimeglumine and gadoxetate disodium
To investigate the utility of interstitial MR lymphography with gadopentetate dimeglumine (Gd‐DTPA) or gadoxetate disodium (Gd… 
Review
2010
Review
2010
Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable?
PURPOSE To test the null hypothesis that there is no quantitative or qualitative difference between respiratory-triggered three… 
2001
2001
Stereospecific binding of MRI contrast agents to human serum albumin: the case of Gd-(S)-EOB-DTPA (Eovist) and its (R) isomer
Abstract. The water proton relaxation rate enhancement of the hepatospecific Gd-(S)-EOB-DTPA (Eovist) and of its (R) isomer in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)